Influenza

The nasal spray is the first vaccine for the prevention of influenza that does not need to be administered by a health care provider.

In this respiratory disease roundup, researchers report on the efficacy of nirmatrelvir-ritonavir for treating Long COVID, the CDC updates recommendations on “triple threat” vaccines for respiratory virus...

The Advisory Committee on Immunization Practices released its updated annual immunization schedule for 2024 that includes new sections on respiratory syncytial virus (RSV), and the mpox (monkeypox) and...

Researchers examined patterns among individuals who previously used preventative services and vaccinations and later vaccinations for both influenza and COVID-19 among US adults.

The CDC updated its guidance due to the United States seeing fewer hospitalizations associated with COVID-19 and because there are numerous tools to combat influenza, COVID-19, and respiratory syncytial...

In a prospective study, researchers evaluated the immune response and adverse events of COVID-19 and seasonal influenza vaccine coadministration.

Many pediatric patients who are recommended to receive two doses of the influenza vaccine do not receive both doses, despite vaccinations being associated with a significant decrease in the risk of...

After an ongoing study, the FDA approves the first vaccine for the highly contagious respiratory virus for us in the United States.